Public Profile

Sandoz Inc.

Sandoz Inc., a prominent global leader in the pharmaceutical industry, is headquartered in the United States and operates extensively across North America, Europe, and Asia. Founded in 1886, Sandoz has established itself as a key player in generic pharmaceuticals and biosimilars, focusing on high-quality, affordable medications that enhance patient access to essential treatments. The company is renowned for its diverse portfolio, which includes a wide range of generic medicines, biosimilars, and over-the-counter products. Sandoz's commitment to innovation and quality sets it apart, as it continually invests in research and development to bring new therapies to market. With a strong market position, Sandoz has achieved notable milestones, including numerous successful product launches and a reputation for reliability in the healthcare sector.

DitchCarbon Score

How does Sandoz Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

23

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Sandoz Inc.'s score of 23 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Sandoz Inc.'s reported carbon emissions

Sandoz Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. As a leading player in the pharmaceutical industry, Sandoz is expected to align with industry standards for climate commitments. While no specific emissions figures or reduction initiatives have been disclosed, the company is likely to be engaged in efforts to address climate change and reduce its carbon footprint in line with global sustainability trends. Further information on their climate commitments may be forthcoming as the industry increasingly prioritises environmental responsibility.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Sandoz Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Sandoz Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Sandoz Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Aurobindo Pharma USA, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Genentech

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Dr. Reddy's Laboratories Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Talphera, Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Hikma Labs Inc.

US
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Roche Holding AG

CH
Pharmaceutical Preparation Manufacturing
Updated 1 day ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers